Celltrion Pharm signed a trilateral agreement with Becton Dickinson France and BD Korea, combining its CMO capabilities with ...

Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $17 million contract modification from the Biomedical Advanced Research and Development Authority (BARDA), part of the ...

Mycenax Biotech Inc. (TWO:4726), a leading biologics CDMO based in Taiwan, today announced strategic alliance with SPERA PHARMA Inc., ...

Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them.

Cytiva demonstrates that manufacturers must expand their focus to include strategic liquid planning for scale-up.